Inactive enantiomer of A-908292 with approximately 50-fold less activity against ACC2, also causing a similar reduction in glucose and triglycerides

Selective dopamine receptor D1 agonist

Potent and selective α4β2 nACh receptor agonist

Highly selective agonist of α4β2 subtype of neural nicotinic acetylcholine receptors

Selective α7 nicotinic acetylcholine receptor (nAChR) agonist

High affinity α2-adrenoceptor antagonist and selective 5-HT uptake inhibitor

Potent and selective cannabinoid CB2 receptor agonist

Negative control for A-745

Potent CCK1 agonist

Potent and selective α7 nAChR partial agonist

Potent and selective AKT>Akt kinases inhibitor

Novel transient receptor potential type V1 receptor antagonist

Novel α4β2 neuronal nicotinic receptor positive allosteric modulator

Selective H3 antagonist

Cannabinoid agonist; Analgesic

Multidrug Resistance (MDR) Modulator

Novel Bcl-XL antagonist

Nicotinic acetylcholine receptor agonist

Selective nonimidazole H3 receptor inverse agonist

Novel and selective H3 receptor antagonist

Multidrug Resistance (MDR) Modulator

Novel adenosine A2A receptor (A2AR) antagonist

Novel potent and orally active adenosine kinase inhibitor

Novel potassium channel opener, more potent enantiomer

Negative control for A-192621

Selective adenosine kinase (AK) inhibitor

Novel blocker of the activation of the TRPV1 channel by capsaicin, inducing hypothermia involving tail-skin, vasodilation at thermoneutrality, decreasing body temperature

Temperature-Neutral Transient Receptor Potential Vanilloid-1 (TRPV1) Antagonist with Analgesic Efficacy

Fluorogenic A9 Peptide Probe, Interacting with Its Receptor Model HER2-DIVMP

Selective TRPV1 antagonist